Toggle navigation
Home
Search
Services
Blog
Contact
About
Biologically Relevant Alpha Helix Stabilization
Erlanson, Daniel A.
Sunesis Pharmaceuticals, Inc., South San Francisco, CA, United States
Search 5 grants from Daniel Erlanson
Search grants from Sunesis Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
RA Comorbidity Bone Health in Men and African Americans
Enhancing EP-Performed Alcohol Interventions in the ED
Prevention of Depression in School Children
Drug Metabolizing Enzymes - Risk Factors in Bladder CA
Interaction of Ethanol with NMDA Receptor Subtypes
Recently added grants:
Mechanism of Infectivity Acquisition in African Trypanosomes
The Mechanism of Arenavirus Entry into Cells
Integrated Exchange and Storage of Current- and Future-Generation Immunogenomic Data
Imaging of Single HIV-1 Uncoating and Transport to the nucleus
National Jewish Health CoFAR Clinical Research Unit
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
7F32GM019454-02
Application #
2906476
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Lohrey, Nancy
Project Start
1998-12-21
Project End
Budget Start
1998-12-21
Budget End
1999-03-08
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Sunesis Pharmaceuticals, Inc.
Department
Type
DUNS #
City
South San Francisco
State
CA
Country
United States
Zip Code
94080
Comments
Be the first to comment on Daniel Erlanson's grant